Home » Topics » Regulatory

Regulatory
RSS

Indications for Forcaltonin expanded in Europe

July 3, 2003

Positive opinion for Onsenal in familial adenomatous polyposis in Europe

July 3, 2003

FDA advisory committee issues positive decision on Photofrin PDT efficacy in Barrett's esophagus

July 3, 2003

Approvable letter issued for Wellbutrin XL

July 3, 2003

Requip OCR enters phase III testing

July 3, 2003

Bexxar approved by FDA

July 2, 2003

Enbrel recommended by FDA panel to treat ankylosing spondylitis

June 30, 2003

Gemzar/Taxol approved in Finland for metastatic breast cancer

June 27, 2003

FDA approval of Striant for testosterone replacement therapy

June 25, 2003

FDA approves Reyataz for HIV-1 infection

June 25, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 6, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 6, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.